Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Sell

Mirion Technologies, Inc. (MIR)

Measuring & Controlling Devices, Nec

https://www.mirion.com

Mirion Technologies Inc provides products, services, and software that allows customers to safely leverage the power of ionizing radiation for the greater good of humanity through critical applications in the medical, nuclear, defense markets, as well as laboratories, scientific research, analysis and exploration. The Company manages its operations through two segments: Medical and Industrial. The Medical segment provides radiation oncology quality assurance, delivering patient safety solutions for diagnostic imaging and radiation therapy centers. The Industrial segment provides robust, field ready personal radiation detection and identification equipment for defense applications and radiation detection and analysis tools for power plants, labs, and research applications.

1218 MENLO DRIVE
ATLANTA, GA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

08/20/2020

Market Cap

2,373,588,360

Shares Outstanding

217,970,000

Weighted SO

217,972,305

Total Employees

N/A

Upcoming Earnings

08/07/2024

Beta

0.7900

Last Div

0.0000

Range

6.7-11.78

Chg

-0.0300

Avg Vol

933380

Mkt Cap

2373588360

Exch

NYSE

Country

US

Phone

770 432 2744

DCF Diff

14.2005

DCF

-3.6754

Div Yield

0.0000

P/S

2.8900

EV Multiple

18.4242

P/FV

1.4121

Div Yield %

0.0000

P/E

-32.8570

PEG

-1.5005

Payout

0.0000

Current Ratio

2.1820

Quick Ratio

1.5542

Cash Ratio

0.5195

DSO

92.6610

DIO

102.4986

Op Cycle

195.1596

DPO

36.0784

CCC

159.0812

Gross Margin

0.3570

Op Margin

0.0017

Pretax Margin

-0.0832

Net Margin

-0.0789

Eff Tax Rate

0.0351

ROA

-0.0247

ROE

-0.0437

ROCE

0.0006

NI/EBT

0.9488

EBT/EBIT

-48.7857

EBIT/Rev

0.0017

Debt Ratio

0.2629

D/E

0.4582

LT Debt/Cap

0.3121

Total Debt/Cap

0.3142

Int Coverage

0.0226

CF/Debt

0.1602

Equity Multi

1.7425

Rec Turnover

3.9391

Pay Turnover

10.1169

Inv Turnover

3.5610

FA Turnover

4.7529

Asset Turnover

0.3126

OCF/Share

0.5475

FCF/Share

0.3239

Cash/Share

0.6345

OCF/Sales

0.1348

FCF/OCF

0.5917

CF Coverage

0.1602

ST Coverage

16.2794

CapEx Coverage

2.4491

Div&CapEx Cov

2.4491

P/BV

1.4121

P/B

1.4121

P/S

2.8900

P/E

-32.8570

P/FCF

36.2380

P/OCF

19.2334

P/CF

19.2334

PEG

-1.5005

P/S

2.8900

EV Multiple

18.4242

P/FV

1.4121

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Feb 12, 04:05 CLARIFICATION: Evome Medical Technologies Announces Significant Debt Restructuring Benzinga Jan 11, 13:00 Where Mirum Pharmaceuticals Stands With Analysts Benzinga Dec 19, 13:00 The Latest Analyst Ratings For Mirum Pharmaceuticals Benzinga Dec 19, 07:30 Uber To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Tuesday Benzinga Nov 27, 13:41 Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session Benzinga Nov 20, 10:00 11 Analysts Have This to Say About Mirum Pharmaceuticals Benzinga Nov 03, 11:00 Analyst Ratings for Mirum Pharmaceuticals GlobeNewswire Inc. Oct 30, 06:05 United Therapeutics to Acquire Miromatrix Medical Benzinga Oct 24, 11:00 Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023

Revenue Product Segmentation